See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
AstraZeneca PLC (AZN) - free report >>
Johnson & Johnson (JNJ) - free report >>
Pfizer Inc. (PFE) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
AstraZeneca PLC (AZN) - free report >>
Johnson & Johnson (JNJ) - free report >>
Pfizer Inc. (PFE) - free report >>
Image: Bigstock
Update on the COVID Vaccine Race
According to our Chief Equity Strategist and Economist, John Blank, COVID19 treatments and vaccines are a KEY to any global recovery in 2021. He’s with me now.
1. What can you share with us along this line, as the markets are currently trying to balance Covid-19 vaccine concerns with other fundamentals?
2. As the market is forward looking, what signal is it sending regarding the race for a vaccine? That race seems to be a key factor here. Some argue that our economy is recovering at a decent pace without a vaccine. Are you saying that a vaccine would increase the recovery here exponentially?
3. What can be said about the approach to combat this virus that countries in general have taken, because the trend of rising cases varies from country to country correct?
4. If the rising trend continues long term, how soon before health care providers start to feel stressed?
5. What impact will that have on the economy?
6. There are a number of companies with vaccines in testing in the race to come up with THE one. For investors thinking about buying into some of them, given the race for THE first vaccine what specific challenges to stocks of those companies must investors be aware of?
7. You’ve listed them in order of relevance and there are five this time. Gilead (GILD - Free Report) , Pfizer (PFE - Free Report) , Moderna (MRNA - Free Report) , Johnson & Johnson (JNJ - Free Report) and Astra Zeneca (AZN - Free Report) .
Our Chief Equity Strategist & Economist, John Blank, Cracking The Book on Covid-19 treatments and vaccines as that pertains to the economy. With John, I’m Terry Ruffolo.